Therapeutic cell-based vaccines for glioblastoma multiforme
/in Dendritic Cells, Glioblastoma, International Publications /von 2023-11-12 / Med Oncol 2023 Nov;40(12):354Neue IOZK Veröffentlichung zum Thema Liquid Biopsy
/in IOZK Aktuelles, IOZK Veröffentlichungen /von IOZKRadioimmunotherapy With WT1 Dendritic Cell Vaccine for End-Stage Lung Adenocarcinoma Markedly Shrinks Tumors
/in Dendritic Cells, International Publications, NSCLC /von 2023-11-06 / Cureus 2023 Nov;15(11):e48412The DC-T cell axis is an effective target for the treatment of non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2023-11-01 / Immun Inflamm Dis 2023 Nov;11(11):e1099
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution